AKT1 and breast cancer: Mechanistically, circSLC8A1 could adsorb miR-671 to enhance the expression of KLF16, a transcriptional activator of PTEN, thereby upregulating PTEN and subsequently inactivating PI3k/Akt signaling, ultimately inhibiting BC tumorigenesis [77].